micotil 300 mg/ml injekční roztok
elanco gmbh - tilmikosin - injekční roztok - makrolidy - skot, ovce
tilmisone 300 mg/ml injekční roztok
vetpharma ah, s.l. - tilmikosin - injekční roztok - 300mg/ml - makrolidy - skot, ovce
micorion 300 mg/ml injekční roztok
vetpharma ah, s.l. - tilmikosin - injekční roztok - makrolidy - skot, ovce
spizobactin 1 500 000 iu/250 mg 1500000 iu/250 mg Žvýkací tableta
le vet beheer, b.v. - spiramycinu a metronidazolu - Žvýkací tableta - kombinace antibakteriální - psi
spizobactin 3 000 000 iu/500 mg 3000000 iu/500 mg Žvýkací tableta
le vet beheer, b.v. - spiramycinu a metronidazolu - Žvýkací tableta - kombinace antibakteriální - psi
spizobactin 750 000 iu/125 mg 750000 iu/125 mg Žvýkací tableta
le vet beheer, b.v. - spiramycinu a metronidazolu - Žvýkací tableta - kombinace antibakteriální - psi
libtayo
regeneron ireland designated activity company (dac) - cemiplimab - karcinom, skvamózní buňka - antineoplastická činidla - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.
tilminject 300 mg/ml injekční roztok
laboratorios calier s.a. - tilmikosin - injekční roztok - makrolidy - ovce, skot
clavaseptin 750 mg tableta
vetoquinol s.r.o. - amoxicillin and beta-lactamase inhibitor - tableta - kombinace penicilinů, včetně. beta-laktamázy inhibitory - psi
actynox 50%/50% medicinální plyn, stlačený
air products spol. s r.o., děčín array - 2473 oxid dusnÝ; 3084 kyslÍk - medicinální plyn, stlačený - 50%/50% - oxid dusnÝ, kombinace